Has Fahd Mousa, MD received payments from drug or device companies?

Yes. Drug and device makers reported $199,789 in general payments to Fahd Mousa, MD across 369 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Fahd Mousa, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Fahd Mousa, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Fahd Mousa, MD

Psychiatry · Charleston, WVNPI 1588026124

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $169,399 of the $199,789 with a category attached, or 84.8%. 13 manufacturers reported payments, led by Axsome Therapeutics, Inc. at 43.2% of the total. 2025 is the largest year on record at $150,450, more than ten times the $427 reported in 2019. Among psychiatry clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$199,789in general payments, 2019–2025

Across 369 payments — averaging $541.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Axsome Therapeutics, Inc.$86K
Otsuka America Pharmaceutical, Inc.$84K
Teva Pharmaceuticals USA, Inc.$27K
Johnson & Johnson$563
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$485
E.r. Squibb & Sons, L.L.C.$467
plus $1K from 7 others

What the payments were for

Speaking & faculty fees$169,39985%
Travel & lodging$17,6029%
Food & beverage$12,7616%
Education$270%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Axsome Therapeutics, Inc.	139	$86,381
Otsuka America Pharmaceutical, Inc.	165	$83,800
Teva Pharmaceuticals USA, Inc.	32	$26,668
Johnson & Johnson	7	$563
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	4	$485
E.r. Squibb & Sons, L.L.C.	4	$467
Alkermes, Inc.	5	$440
AbbVie(2 entities)	4	$350
Lundbeck LLC	4	$189
Regeneron Healthcare Solutions, Inc.	1	$130
Astellas Pharma US Inc	1	$115
Ironshore Pharmaceuticals Inc.	1	$107
Otsuka Pharmaceutical Development & Commercialization, Inc.	2	$94

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Auvelity$83,217
ABILIFY MAINTENA$42,918
ABILIFY ASIMTUFII$40,898
REXULTI$38,152
UZEDY$26,291
CAPLYTA$485
ARISTADA$480
LYBALVI$409
VRAYLAR$336
INVEGA SUSTENNA$238
COBENFY$234
LIBTAYO$130
INVEGA TRINZA$125
ELIQUIS$122
ARISTADA INITIO$120
XTANDI$115
Jornay PM 20mg capsules (Bottle of 100)$107
VIVITROL$105

How this compares

$199,789 in reported general payments places this provider in the 95th percentile of 177 psychiatry providers in West Virginia.

See all psychiatry providers in West Virginia →

Medicare billing

Part B allowed, 2024

$40,046

Medicare patients

122

Services billed

750

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Aripiprazole	16	$895
Divalproex Sodium	18	$255
Mirtazapine	14	$128
Trazodone Hcl	13	$104
Lithium Carbonate ErLithium Carbonate	13	$99
Hydroxyzine Pamoate	21	$99
Duloxetine Hcl	12	$88
Buspirone Hcl	16	$71
Quetiapine Fumarate	17	$45
Sertraline Hcl	12	$36
Escitalopram Oxalate	13	$35

Paid to pharmacies, not to this prescriber.

Other psychiatry in Charleston

Melissa MoodyCharleston$1.2M
Lawrence KellyCharleston$41K
Sidney LerfaldCharleston$14K
Kiran DevarajCharleston$9K
Krista RhodesCharleston$4K
Veena BhanotCharleston$833
Timothy ThistlethwaiteCharleston$773
Nohl BraunCharleston$612
April BaisdenScott Depot$775K
Ryan WakimWheeling$772K

See the full list for West Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →